Multitrial evaluation of progression-free survival (PFS) as a surrogate endpoint for overall survival (OS) in previously untreated extensive-stage small cell lung cancer (ES-SCLC): An Alliance-led analysis
- Citation:
- J Clin Oncol vol 31 (15 suppl) abstr 7510
- Meeting Instance:
- ASCO 2013
- Year:
- 2013
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Meta-Analysis
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- 2091
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- N. R. Foster L. A. Renfro S. E. Schild M. W. Redman X. F. Wang S. E. Dahlberg K. Ding P. A. Bradbury S. S. Ramalingam D. R. Gandara E. E. Vokes A. A. Adjei S. J. Mandrekar
- Networks:
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- Comprehensive, CALGB-9033, CALGB-9732, CALGB-30103, NCCTG-862051, NCCTG-892051, NCCTG-932053, ECOG-1500, ECOG-7593, JCOG-9511, NCIC-BR4, NCIC-BR8, SWOG-S0124
- Phases:
- 2, 3, N/A
- Keywords: